Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia

PD Tamma, JH Han, C Rock, AD Harris… - Clinical Infectious …, 2015 - academic.oup.com
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …
被引用次数：363 相关文章
[PDF] iavante.es

[PDF][PDF] Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase …

PD Tamma, JH Han, C Rock, AD Harris… - Clinical Infectious …, 2015 - pirasoa.iavante.es
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …
[PDF] psu.edu

[PDF][PDF] Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase …

PD Tamma, JH Han, C Rock, AD Harris… - Clinical Infectious …, 2015 - Citeseer
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.

PD Tamma, JH Han, C Rock, AD Harris… - Clinical Infectious …, 2015 - cabdirect.org
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia

PD Tamma, JH Han, C Rock… - Clinical Infectious …, 2015 - pure.johnshopkins.edu
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.

PD Tamma, JH Han, C Rock, AD Harris, E Lautenbach… - 2015 - cabidigitallibrary.org
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia

PD Tamma, JH Han, C Rock… - … publication of the …, 2015 - pubmed.ncbi.nlm.nih.gov
Background The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of extended-
spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day mortality of …

[引用][C] Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum-Lactamase …

PD Tamma, JH Han, C Rock, AD Harris… - Clinical Infectious …, 2015 - cir.nii.ac.jp
Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam
for Patients With Extended-Spectrum -Lactamase Bacteremia | CiNii Research CiNii 国立情報学 …

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.

PD Tamma, JH Han, C Rock, AD Harris… - … Diseases: an Official …, 2015 - europepmc.org
Background The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of extended-
spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day mortality of …

Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia.

PD Tamma, JH Han, C Rock… - Clinical Infectious …, 2015 - search.ebscohost.com
Background. The effectiveness of piperacillin-tazobactam (PTZ) for the treatment of
extended-spectrum β-lactamase (ESBL) bacteremia is controversial. We compared 14-day …